Blue Cross and Blue Shield of Texas recently announced that they will be removing Houston’s MD Anderson Cancer Center from their Medicare and Medicaid networks. This decision has sparked concern among patients who rely on MD Anderson for cancer treatment.
The decision is set to take effect on October 31, 2021, and will impact approximately 100,000 Blue Cross and Blue Shield members who use MD Anderson for their cancer care. The insurance company stated that their contract with MD Anderson was not cost-effective and that they were unable to reach an agreement on reimbursement rates.
MD Anderson is a renowned cancer center that is widely respected for its cutting-edge research and treatment programs. Many patients choose to receive care at MD Anderson because of its reputation for providing top-quality cancer care. The removal of MD Anderson from the Blue Cross and Blue Shield network will force patients to seek treatment elsewhere, potentially disrupting their care and causing additional stress during an already challenging time.
In response to the decision, MD Anderson has stated that they are disappointed and are working to reach a resolution with Blue Cross and Blue Shield. They are urging patients affected by the change to reach out to their insurance company to discuss their options and ensure that they can continue to receive the care they need.
Overall, the removal of MD Anderson from the Blue Cross and Blue Shield network highlights the challenges faced by patients and healthcare providers in navigating the complex world of insurance coverage. It serves as a reminder of the importance of advocating for access to quality healthcare and the need for transparent communication between insurers, providers, and patients.
Source
Photo credit news.google.com